Parametrica Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,800
Closed -$1.59M 83
2024
Q3
$1.59M Sell
1,800
-3,300
-65% -$2.97M 1.9% 16
2024
Q2
$4.62M Buy
+5,100
New +$4.08M 6.11% 5
2024
Q1
Sell
-1,184
Closed -$690K 28
2023
Q4
$690K Sell
1,184
-4,809
-80% -$2.81M 1.13% 24
2023
Q3
$3.22M Sell
5,993
-1,782
-23% -$918K 5.42% 7
2023
Q2
$3.65M Sell
7,775
-52
-0.7% -$21.8K 7.02% 4
2023
Q1
$2.69M Buy
7,827
+627
+9% +$211K 4.85% 7
2022
Q4
$2.63M Buy
7,200
+2,283
+46% +$809K 5.4% 6
2022
Q3
$1.59M Sell
4,917
-641
-12% -$203K 3.25% 10
2022
Q2
$1.81M Buy
+5,558
New +$1.67M 1.97% 10
2020
Q4
Sell
-2,225
Closed -$329K 186
2020
Q3
$329K Buy
+2,225
New +$344K 0.62% 48
2018
Q4
Sell
-2,468
Closed -$265K 296
2018
Q3
$265K Buy
+2,468
New +$247K 0.58% 80
2017
Q2
Sell
-2,874
Closed -$242K 326
2017
Q1
$242K Buy
+2,874
New +$230K 0.25% 205
2016
Q3
Sell
-2,751
Closed -$217K 194
2016
Q2
$217K Buy
+2,751
New +$207K 0.32% 162

Other funds holding LLY

Parametrica Management's LLY Position: Q4 2024 in Review

Parametrica Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 1,800 shares — an estimated $1.59M sold.

Parametrica Management first reported a position in LLY in Q2 2016 and held it in 13 quarters. The position peaked at $4.62M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Parametrica Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Parametrica Management sold 1,800 Eli Lilly shares in Q4 2024, an estimated $1.59M.
  • Parametrica Management first reported a position in Eli Lilly in Q2 2016 and held it in 13 quarters.
  • Parametrica Management's Eli Lilly position peaked at $4.62M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Parametrica Management's 13F filing for Q4 2024, filed 12 Feb 2025.